# Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - Inspection Records Source: https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968 > Inspection records and compliance data for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company in Manati, Puerto Rico. Access full analysis and detailed observations. --- ## Details - Name: Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - FEI Number: 2650089 - City: Manati - State: Puerto Rico - Country Name: United States - Address Line 1: Rd # 686, Km # 2.3, Sector Cotto Norte, Bo. Tierras Nuevas - Zip Code: 00674 ## Related Documents - [483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2026-02-13](https://www.keypedia.com/records/483/bristol-myers-squibb-holdings-pharma-ltd-liability-company/473e5d65-fa74-4039-931e-190b8cca243e) — source: FDA, date: February 13, 2026 - [483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2026-02-13](https://www.keypedia.com/records/483/bristol-myers-squibb-holdings-pharma-ltd-liability-company/7c681e62-206a-4b13-9b4b-45a6ce8021b0) — source: FDA, date: February 13, 2026 - [FDA Inspection 1305236 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2026-02-13](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/d4edb78e-8539-4958-aa1f-3f9b7c722066) — source: FDA, date: February 13, 2026 - [FDA Inspection 1242629 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2024-06-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/05545f68-893b-4e52-95ad-633611824057) — source: FDA, date: June 6, 2024 - [EIR - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2021-07-12](https://www.keypedia.com/records/eir/bristol-myers-squibb-holdings-pharma-ltd-liability-company/56eb7270-8288-4e2e-9fa8-6dc4172554f0) — source: FDA, date: July 12, 2021 - [483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2021-07-12](https://www.keypedia.com/records/483/bristol-myers-squibb-holdings-pharma-ltd-liability-company/3d31f49a-c3dd-4feb-9a88-ddfd46449760) — source: FDA, date: July 12, 2021 - [FDA Inspection 1147009 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2021-07-12](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/9fcd9e71-f132-4105-8b68-5dc2df75c023) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2021 - [FDA Inspection 1147009 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2021-07-12](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/13fb3933-f63f-4abe-99ce-c7f89d541a37) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2021 - [483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2019-11-19](https://www.keypedia.com/records/483/bristol-myers-squibb-holdings-pharma-ltd-liability-company/1a7ca172-8509-4f22-b87f-30ac950c30a1) — source: FDA, date: November 19, 2019 - [FDA Inspection 1110480 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2019-11-19](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/95d01da7-6768-4d14-9aa2-0bc74e7edaf0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 19, 2019 - [FDA Inspection 1079769 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2019-02-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/723ebad3-1d56-4593-b123-69622c15f890) — classification: Official Action Indicated (OAI), source: FDA, date: February 6, 2019 - [483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2017-09-11](https://www.keypedia.com/records/483/bristol-myers-squibb-holdings-pharma-ltd-liability-company/8e009935-5ba5-495d-8aa2-4f8de0e2e8ae) — source: FDA, date: September 11, 2017 - [FDA Inspection 1030016 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2017-09-11](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/1650c515-0cbd-4eb9-82f5-f588c5791f89) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2017 - [FDA Inspection 986929 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2016-05-18](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64567a32-fa31-4c59-aaca-11f9629cb26b) — classification: No Action Indicated (NAI), source: FDA, date: May 18, 2016 - [FDA Inspection 949087 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2015-11-17](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/35966c20-623e-4e16-9899-9bbed41aae36) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2015 - [FDA Inspection 949087 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2015-11-17](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/6640594c-8ea1-4706-81b7-185a5fb2d88e) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2015 ## Related Companies - [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e) - [AMO (Hangzhou) Co., Ltd.](https://www.keypedia.com/companies/amo-hangzhou-co-ltd/00c065f6-3b50-4050-811e-d03ad3d646e9) - [WES Pharma Inc.](https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d) - [Laboratorios Liconsa SAU](https://www.keypedia.com/companies/laboratorios-liconsa-sau/ab88a2bb-8c52-445d-8417-82ea8f48bdf6) - [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4) - [Med-Pharmex, Inc.](https://www.keypedia.com/companies/med-pharmex-inc/fc3eae98-cbb3-4470-89f2-ef8f616f0a87) - [C. B. Fleet Company, Inc.](https://www.keypedia.com/companies/c-b-fleet-company-inc/f5f5e7fa-8113-4539-bab4-a153edd37d6a) - [Allergan Pharmaceuticals Ireland](https://www.keypedia.com/companies/allergan-pharmaceuticals-ireland/b65756b6-b7d5-438c-a312-93abdd3b372d) - [King Pharmaceuticals LLC](https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5) - [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c) ## Related Officers - [Libia Lugo](https://www.keypedia.com/people/libia-lugo/55f1387e-b6bd-41ca-8507-45829629dac5) - [Investigator](https://www.keypedia.com/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f) - [Investigator](https://www.keypedia.com/people/regina-t-brown/6e2de1b6-3e5d-40ec-8823-7f0aef908b2b) - [Adaliz Santaliz-Cruz](https://www.keypedia.com/people/adaliz-santaliz-cruz/47bd4220-e6cc-4582-a4f5-bd4337f92622)